The 4 most recent market catalysts affecting $BRTX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 3, 2026
Corporate Catalyst
Bearish
Impact 85
BioRestorative Therapies shares are trading lower after the company announced a 1-for-20 reverse stock split.
A 1-for-20 reverse stock split is a strong indicator of a company struggling to maintain its share price, often to avoid delisting from an exchange. While it reduces the number of …
Sep 2, 2026
Corporate Catalyst
Neutral
Impact 75
BioRestorative Therapies Announced Katharyn Field Stepped Aside As Interim CEO And CFO, Appointed Mika Grasso As Interim CEO Effective August 26, Steven Brown As Chairman Effective September 1, 2026
The immediate impact of this news on BRTX is likely neutral to slightly negative due to the inherent uncertainty associated with leadership changes, especially the departure of bot…
Aug 14, 2026
Corporate Catalyst
Bearish
Impact 75
Biorestorative Therapies Suspends All Orders, Shipments Of ExoCR, BioX Biocosmeceutical Product Lines Effective Immediately, On Aug 7; Conducting Review Of The Documentation, Sourcing, Regulatory Status Associated With Suspended Products; Has Not Made Decision To Discontinue Suspended Product Lines
BioRestorative Therapies (BRTX) has announced an immediate suspension of all orders and shipments for its ExoCR and BioX biocosmeceutical product lines. This action is due to an on…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.